Aspen slashes debt after sale of Japanese business
Africa’s biggest drugmaker has over the past year been disposing of noncore assets to manage its debt
05 March 2020 - 20:06
Pharmaceutical manufacturer Aspen Pharmacare said on Thursday it had received R4.6bn from the sale of its Japanese operation and reduced its debt by 2.8% in its latest financial results.
Aspen is Africa’s biggest drugmaker and has over the past year been disposing of noncore assets to manage its debt burden, which it cut from R53.5bn in December 2018 to R38.9bn by the end of June...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.